AEON Biopharma AEON
NYSE AEON
$0.23 +0.00 (+1.26%)
As of: Oct 20, 2026 · 3:59 PM EDT

AEON Biopharma (AEON) Debt Ratio (2020 - 2026)

Updated

AEON Biopharma's (AEON) Debt Ratio was 0.30 for Q2 2026, down 77.2% from 1.30 a year earlier.

Analysis

AEON Biopharma (AEON) Debt Ratio (2020 - 2026) Analysis & Trends

For FY2025, Debt Ratio at AEON Biopharma was 6.22, up 67.3% from FY2024.

  • By year, Debt Ratio came in at 3.72 in FY2024 and 8.72 in FY2022.
  • The Q2 2026 figure ranks as the lowest quarterly Debt Ratio since Q1 2021.
  • Year over year, Debt Ratio gained in 1 of the last five quarters, with an average decline of 28.9%.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 0.39
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn 0.24
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn 0.52
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn 0.42
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 0.08
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn 0.28
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn 0.60
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn 0.53
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn 0.31
10 AEON Biopharma 11.93 Mn -8.87 Mn - 0.30
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.30
Dec 31, 2025 6.22
Sep 30, 2025 1.95
Jun 30, 2025 1.30
Mar 31, 2025 0.97
Dec 31, 2024 3.72
Sep 30, 2024 3.79
Jun 30, 2024 2.32
Mar 31, 2024 1.68
Jun 30, 2023 0.05
Mar 31, 2023 0.01
Dec 31, 2022 8.72
Mar 31, 2021 0.00
Dec 31, 2020 0.48
API Access

AEON Biopharma Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=AEON&period=max&api_key=YOUR_API_KEY